Physician profile
Mitchell Bloomquist
NPI 1891357612
$3,194.00
in general payments reported to CMS, 2019-2025
17 companies · $401 in 2025
The $401 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $669 · 2023: $1,250 · 2024: $749 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,790 · Travel and Lodging: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,789.77 |
| Travel and Lodging | $610.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,050.33 | 2022-2024 | |
| Stryker Corporation | $624.37 | 2022-2025 | Augment Injectable, Swanson, Citrefix |
| Trice Medical, INC. | $343.36 | 2022 | |
| Bioventus LLC | $185.71 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Kerecis Limited | $158.19 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medline Industries Lp | $145.84 | 2022 | |
| Next Science LLC | $133.70 | 2023 | Surgx, Xperience, Blastx |
| Crossroads Extremity Systems, LLC | $124.95 | 2021 | |
| Medtronic, INC. | $106.77 | 2023 | Intellis Adaptivestim |
| Curonix LLC | $104.96 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $91.22 | 2022 | |
| Depuy Synthes Sales INC. | $34.25 | 2025 | Motoband |
| Globus Medical, INC. | $22.47 | 2025 | Senza |
| Nevro Corp. | $21.23 | 2024 | Senza |
| Pylant Medical | $16.99 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $16.15 | 2025 | Dynasplint |
| Ultragenyx Pharmaceutical INC. | $13.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Bloomquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.